Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-results of the Swedish early decision reperfusion study (SWEDES) trial

American Heart Journal

Volumn 160, Issue 2, 2010, Pages 322-328

  Aasa, Mikael ^a,d   Henriksson, Martin ^b   Dellborg, Mikael ^c   Grip, Lars ^c   Herlitz, Johan ^c   Levin, Lars Åke ^b   Svensson, Leif ^d   Janzon, Magnus ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d STOCKHOLM SÖDER HOSPITAL   (Sweden)

^e LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ENOXAPARIN; RETEPLASE;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BOOTSTRAPPING; CARDIOPULMONARY EXERCISE TEST; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEALTH CARE COST; HEART CATHETERIZATION; HOSPITALIZATION COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; OVERALL SURVIVAL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; WELLBEING;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COST-BENEFIT ANALYSIS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SWEDEN; THROMBOLYTIC THERAPY;

EID: 77955437434     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.05.008     Document Type: Article

References (20)

1. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
2. Van de Werf F., Ardissino D., and Betriu A. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 24 2003 28 66
3. Antman E.M., Anbe D.T., and Armstrong P.W. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 44 2004 671 719
4. De Boer M.J., Van Hout B.A., and Liem A.L. A cost-effectiveness analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction Am J Cardiol 76 1995 830 833
5. Stone G.W., Grines C.L., and Rothbaum D. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the primary angioplasty in myocardial infarction (PAMI) trial J Am Coll Cardiol 29 1997 901 907
6. Le May M.R., Davies R.F., and Labinaz M. Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction. Cost analysis of the Canadian STAT study Circulation 108 2003 2624 2630
7. Machecourt J., Bonnefoy E., and Vanzetto G. Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center. The Comparison of Angioplasty and Pre-hospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) cost-efficacy sub-study J Am Coll Cardiol 45 2005 515 524
8. Selmer R., Halvorsen S., and Myhre K.I. Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction Scand Cardiovasc J 39 2005 276 285
9. Svensson L., Aasa M., and Dellborg M. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated by abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish early decision (SWEDES) reperfusion trial Am Heart J 151 2006 798.e1 798.e7
10. Janzon M., Levin L.Å., and Swahn E. Cost-effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease Eur Heart J 23 2002 31 40
11. SCB, Statistics Sweden, 2008.
12. Brooks R. EuroQol: the current state of play Health Policy 37 1996 53 72
13. Dolan P. Modeling valuations for EuroQol health states Med Care 35 1997 1095 1108
14. Simoons M.L., Vos J., and Martens L.L. Cost-utility analysis of thrombolytic therapy Eur Heart J 12 1991 694 699
15. Efron B., and Tibshirani R.J. An introduction to the bootstrap Monograph on statistics and applied probability Vol. 57 1993 Chapman and Hall London
16. Bonnefoy E., Lapostolle F., and Leizorovicz A. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study Lancet 360 2002 825 829 (Pubitemid 35257945)
17. Aversano T., Aversano L.T., and Passamani E. Thrombolytic therapy vs. primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial JAMA 287 2002 1943 1951 (Pubitemid 34309752)
18. Grines C.L., Westerhausen D.R., and Grines L.L. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction J Am Coll Cardiol 39 2002 1713 1719
19. Van de Werf F., Bax J., and Betriu A. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
20. Kushner F.G., Hand M., and Smith S.C. Jr ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 2009 focused updates: guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241